About Vistapath
Vistapath is a company based in Cambridge (United States) founded in 2016 by Ben Burley and Timothy Spong. Vistapath has raised $13.82 million across 7 funding rounds from investors including NextGen Venture Partners, Moxxie Ventures and First Star Ventures. The company has 6 employees as of December 31, 2021. Vistapath offers products and services including Sentinel. Vistapath operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
- Headquarter Cambridge, United States
- Employees 6 as on 31 Dec, 2021
- Founders Ben Burley, Timothy Spong
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vistapath, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.82 M (USD)
in 7 rounds
-
Latest Funding Round
$4.44 M (USD), Seed
Jul 07, 2023
-
Investors
NextGen Venture Partners
& 2 more
-
Employee Count
6
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vistapath
Vistapath offers a comprehensive portfolio of products and services, including Sentinel.
End-to-end solution for optimizing lab workflows with AI
Funding Insights of Vistapath
Vistapath has successfully raised a total of $13.82M across 7 strategic funding rounds. The most recent funding activity was a Seed round of $4.44 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vistapath
Vistapath has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include NextGen Venture Partners, Moxxie Ventures and First Star Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in tech startups are provided by Moxxie Ventures.
|
Locked | Locked | Locked | |
|
Venture capital investments are directed toward multiple sectors.
|
Locked | Locked | Locked | |
|
Investments in technology startups are made by First Star Ventures.
|
Locked | Locked | Locked |
Investor details for Vistapath
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vistapath
Investment portfolio details for Vistapath
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vistapath
Detailed financials for Vistapath
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vistapath Comparisons
Peer comparison for Vistapath
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vistapath
Vistapath operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| Locked | Locked | Locked |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| Locked | Locked | Locked |
AI-based tools for pathological image analysis are provided to labs.
|
Detailed competitors of Vistapath
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vistapath
Complete news archive for Vistapath
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vistapath
Vistapath was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Vistapath is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Timothy Spong is the current CEO of Vistapath. They have also founded this company.
Vistapath is a funded company, having raised a total of $13.82M across 7 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Vistapath is 6.
Vistapath was founded in 2016 in Cambridge, United States, as a platform focused on AI and cloud technologies for pathology processing. Diagnostic support is provided through automated analysis of medical images and data. Operations center on healthcare technology, with services including workflow optimization for pathologists. The company is led by co-founders Ben Burley and Timothy Spong, who serves as CEO.
Vistapath's top competitors include Aignostics, Deciphex and Pictor Labs.
Vistapath offers Sentinel.
Vistapath has 3 investors. Key investors include NextGen Venture Partners, Moxxie Ventures, and First Star Ventures.